Literature DB >> 15196709

Blastocyst freezing.

Yves J R Ménézo1.   

Abstract

Blastocyst are preimplantation embryos that have successfully passed the critical step of genomic activation and have so a high developmental potential, thus allowing to reduce the number of embryos transferred. Blastocyst culture and freezing have really started in IVF programs in the early nineties, when it was possible to obtain good blastocysts (essentially using coculture) on a large scale. Blastocysts freezing has been performed since the beginning using glycerol as cryoprotectant in slow protocols. The transition from coculture to sequential media has been a little bit delicate with a drop in the results. Few modifications including a change in the freezing curves and thawing at 37 degrees C have allowed to reach the same results with the two culture techniques. Vitrification with ethylene glycol (EG) has been proposed recently. However, the toxicity of the metabolites of EG for rat embryos has to be considered before moving to this technology on a large scale.

Entities:  

Mesh:

Year:  2004        PMID: 15196709     DOI: 10.1016/j.ejogrb.2004.01.007

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Vitrification of human early cavitating and deflated expanded blastocysts: clinical outcome of 474 cycles.

Authors:  G A Rama Raju; G Jaya Prakash; K Murali Krishna; K Madan
Journal:  J Assist Reprod Genet       Date:  2009-10-30       Impact factor: 3.412

2.  Successful pregnancy following the transfer of vitrified blastocyst which developed from poor quality embryos on day 3.

Authors:  Xiao-Jian Zhang; Ye-Zhou Yang; Li-Hua Min; Qun Lv; Pin Bai; Xiao-Jie Li; Mei-Xu Liao
Journal:  Iran J Reprod Med       Date:  2011

3.  Effects of Re-Vitrification of Mouse Morula and Early Blastocyst Stages on Apoptotic Gene Expression and Developmental Potential.

Authors:  Nasrin Majidi Gharenaz; Mansoureh Movahedin; Zohreh Mazaheri
Journal:  Cell J       Date:  2017-11-04       Impact factor: 2.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.